tiprankstipranks
CirChem AB (SE:CIRCHE)
:CIRCHE
Want to see SE:CIRCHE full AI Analyst Report?

CirChem AB (CIRCHE) AI Stock Analysis

2 Followers

Top Page

SE:CIRCHE

CirChem AB

(CIRCHE)

Select Model
Select Model
Select Model
Neutral 49 (OpenAI - 5.2)
Rating:49Neutral
Price Target:
kr0.99
▲(16.82% Upside)
Action:ReiteratedDate:03/11/26
The score is held back primarily by weak financial performance, driven by sharply lower revenue, sizable losses, and significant negative operating/free cash flow. Technical indicators provide some offset with moderately positive momentum, while valuation remains unattractive/unclear due to negative earnings and no dividend yield data.
Positive Factors
Manageable leverage and equity cushion
Low debt-to-equity (~0.18) and a sizable equity base provide a durable financial cushion, giving the company flexibility to fund operations or restructure without immediate solvency pressure. This balance-sheet strength supports multi-month resilience while losses persist.
Negative Factors
Sharp revenue decline
A near 30% year-over-year revenue decline materially reduces scale and weakens the firm's ability to absorb fixed costs. Sustained top-line contraction undermines margin recovery, contract leverage and long-term growth prospects unless new demand or customer wins reverse the trend.
Read all positive and negative factors
Positive Factors
Negative Factors
Manageable leverage and equity cushion
Low debt-to-equity (~0.18) and a sizable equity base provide a durable financial cushion, giving the company flexibility to fund operations or restructure without immediate solvency pressure. This balance-sheet strength supports multi-month resilience while losses persist.
Read all positive factors

CirChem AB (CIRCHE) vs. iShares MSCI Sweden ETF (EWD)

CirChem AB Business Overview & Revenue Model

Company Description
CirChem AB (publ) engages in recycling of used solvents in Sweden. It collects and purify used industrial solvents for reuse; and produces other chemical products, such as washer fluid and rubbing alcohol. CirChem AB (publ)was founded in 2013 and ...
How the Company Makes Money
CirChem AB’s revenue model is based on providing solvent recycling services and selling recovered solvents back into the market. Key revenue streams would typically include (1) fees charged to industrial customers for collecting, handling, and pro...

CirChem AB Financial Statement Overview

Summary
Financial performance is weak. Income statement deterioration is severe (revenue down ~29.9% YoY with a swing to large operating and net losses). Cash flow is also materially negative (TTM operating cash flow -13.7m; free cash flow -20.6m), indicating meaningful cash burn. The balance sheet is a partial offset with manageable leverage (debt-to-equity ~0.18), but ongoing losses remain the key risk.
Income Statement
22
Negative
Balance Sheet
58
Neutral
Cash Flow
18
Very Negative
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue9.96M20.66M5.75M590.62K85.55K
Gross Profit-11.24M19.53M3.04M2.92M2.62M
EBITDA-10.12M374.00K-15.52M-19.87M-16.74M
Net Income-12.05M-1.07M-17.14M-25.50M-19.48M
Balance Sheet
Total Assets69.47M61.18M59.11M50.30M52.14M
Cash, Cash Equivalents and Short-Term Investments13.65M11.93M16.58M9.78M14.57M
Total Debt12.90M8.92M8.92M1.75M2.00M
Total Liabilities25.14M15.49M24.00M25.17M25.77M
Stockholders Equity44.33M45.68M35.10M25.13M26.37M
Cash Flow
Free Cash Flow-20.57M-12.85M-27.48M-25.27M-5.47M
Operating Cash Flow-13.70M-6.38M-26.68M-21.49M-2.78M
Investing Cash Flow-6.88M-6.47M-798.49K-3.78M-2.69M
Financing Cash Flow22.29M8.20M34.29M20.48M-2.04M

CirChem AB Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.85
Price Trends
50DMA
1.10
Negative
100DMA
1.00
Negative
200DMA
1.39
Negative
Market Momentum
MACD
-0.02
Positive
RSI
44.73
Neutral
STOCH
18.17
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:CIRCHE, the sentiment is Negative. The current price of 0.85 is below the 20-day moving average (MA) of 1.03, below the 50-day MA of 1.10, and below the 200-day MA of 1.39, indicating a bearish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 44.73 is Neutral, neither overbought nor oversold. The STOCH value of 18.17 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:CIRCHE.

CirChem AB Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
53
Neutral
kr108.49M-13.81-17.60%58.33%80.04%
52
Neutral
kr124.72M-6.27-94.54%46.99%16.83%
52
Neutral
kr100.43M45.33-14.54%-25.58%
51
Neutral
kr181.25M42.875.49%-37.17%
49
Neutral
kr38.28M-2.71-25.32%
46
Neutral
kr218.50M-2.12-20.69%-81.53%-634.82%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SE:CIRCHE
CirChem AB
1.00
-1.60
-61.62%
SE:SES
Scandinavian Enviro Systems AB
0.20
-0.65
-76.92%
SE:AXOLOT
Axolot Solutions Holding AB
0.34
-0.08
-19.62%
SE:BIOEX
Bioextrax AB
2.68
0.28
11.76%
SE:SAXG
Saxlund Group AB
14.95
3.55
31.14%
SE:NOTEK
Norditek Group AB
13.15
1.00
8.23%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 11, 2026